Captopril vs Durvalumab

Captopril vs Durvalumab: Overview

This comparison examines the pharmacological differences between Captopril and Durvalumab.

Mechanism of Action

Captopril: First orally active ACE inhibitor; contains thiol group that binds zinc at ACE active site.

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Pharmacokinetics

Half-life: Captopril — 1.9 hours; Durvalumab — 17 days.

Chemical Properties

Molecular Formula: Captopril — C9H15NO3S.

Molecular Weight: Captopril — 217.2850 g/mol.

Type: Captopril — Small molecule; Durvalumab — Antibody.